Gilead receives approval for cheaper hepatitis C drug
June 28, 2016 at 13:43 PM EDT
Gilead Sciences Inc. received U.S. Food and Drug Administration approval for its Epclusa hepatitis C combination drug and priced the treatment below its older drugs for the disease.
